6 pending office actions
| App # | Title | Examiner | Art Unit | Status | Filed |
|---|---|---|---|---|---|
| 18253721 | ADOPTIVE CELL THERAPY FOR TREATMENT OF CANCER ASSOCIATED WITH LOSS OF HETEROZYGOSITY | HECK, BRYAN WILLIAM | 1643 | Non-Final OA | May 19, 2023 |
| 18020837 | COMPOSITIONS AND METHODS FOR TREATING CANCERS | BUTTICE, AUDREY L | 1647 | Non-Final OA | Feb 10, 2023 |
| 18165623 | COMPOSITIONS AND METHODS FOR TREATING EGFR POSITIVE CANCERS | CANELLA, KAREN A | 1643 | Non-Final OA | Feb 07, 2023 |
| 18062873 | COMPOSITIONS AND METHODS FOR TREATING MESOTHELIN POSITIVE CANCERS | SPENCE, JENNIFER SUZANNE | 1633 | Non-Final OA | Dec 07, 2022 |
| 17757056 | NUCLEIC ACID ENCODING LILRB1-BASED CHIMERIC ANTIGEN RECEPTOR | O'BRIEN, LEA S | 1646 | Non-Final OA | Jun 08, 2022 |
| 17480501 | CONTROLLING PROXIMITY OF IMMUNE CELL RECEPTORS | TIWARI, VYOMA SHUBHAM | 1634 | Final Rejection | Sep 21, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial